Motility of the distal portion of the jejunum and pelvic flexure in ponies: effects of six drugs.

The article studies the impact of six drugs on the movement of the distal portion of the jejunum and pelvic flexure in ponies. It was found that neostigmine, xylazine, and atropine sulfate influenced this activity while flunixin meglumine, dipyrone, and panthenol showed no effects.

Procedure and Objective

• The experiment was conducted on four ponies wherein bipolar stainless steel electrodes were surgically inserted. The objective was to track the myoelectrical and mechanical activity of the distal part of the jejunum as well as the pelvic flexure.
• After they understood the normal activities of these sections, they introduced six drugs namely: neostigmine, xylazine, flunixin meglumine, dipyrone, panthenol, and atropine sulfate to observe their effects.

Impact of Various Drugs

• Three drugs, namely flunixin meglumine, dipyrone, and panthenol, did not cause any change in the mobility of the jejunum or the pelvic flexure. This suggests that these drugs do not affect the digestive transit or gut motility in ponies.
• On the contrary, xylazine and atropine sulfate did slow the motility of the distal bit of the jejunum plus the pelvic flexure. In comparison, atropine sulfate’s effects were noticed to be greater and lasted for a longer duration than xylazine. This implies that xylazine and atropine sulfate could possibly affect the normal digestive activities in ponies, potentially causing digestive issues or stagnation.
• Interestingly, neostigmine was found to stimulate propulsive motility, but only in the pelvic flexure. This indicates that neostigmine might help in improving the bowel movements or treat certain types of digestive issues affecting the pelvic flexure in ponies.

Conclusions

• The study’s findings highlight the distinct effects of different drugs on the motility of the jejunum and pelvic flexure in ponies. Some drugs didn’t affect motility, others inhibited it, and one appeared to stimulate it.
• These results contribute to the understanding of how these drugs can influence digestive processes in ponies. This knowledge could be helpful when deciding on medical treatments and managing potential side-effects related to digestive function.